BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3728178)

  • 1. Urinary oxipurinol-1-riboside excretion and allopurinol-induced oroticaciduria.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1986; 195 Pt A():453-60. PubMed ID: 3728178
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dietary purine restriction, allupurinol, and oxipurinol on urinary excretion of ultraviolet-absorbing compounds.
    Kelley WN; Wyngaarden JB
    Clin Chem; 1970 Aug; 16(8):707-13. PubMed ID: 5474201
    [No Abstract]   [Full Text] [Related]  

  • 3. Allopurinol-1-riboside formation and HGPRT-deficiency.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1986; 195 Pt A():447-51. PubMed ID: 3728177
    [No Abstract]   [Full Text] [Related]  

  • 4. On the metabolism of allopurinol. Formation of allopurinol-1-riboside in purine nucleoside phosphorylase deficiency.
    Reiter S; Simmonds HA; Webster DR; Watson AR
    Biochem Pharmacol; 1983 Jul; 32(14):2167-74. PubMed ID: 6409116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purine and pyrimidine metabolism in hereditary oroticaciduria during a 15 year follow-up study.
    Webster DR; Simmonds HA; Potter CF; Becroft DM
    Adv Exp Med Biol; 1979; 122B():203-8. PubMed ID: 546145
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of dietary purines on allopurinol metabolism and allopurinol induced oroticaciduria.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1984; 165 Pt A():323-6. PubMed ID: 6720397
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous determination of plasma and urinary uric acid, xanthine, hypoxanthine, allopurinol, oxipurinol, orotic acid, orotidine and creatinine by high-performance liquid chromatography.
    Miyazaki H; Matsunaga Y; Yoshida K; Arakawa S; Hashimoto M
    J Chromatogr; 1983 May; 274():75-85. PubMed ID: 6874855
    [No Abstract]   [Full Text] [Related]  

  • 8. The allopurinol loading test in detecting obligate heterozygotes for OCT deficiency.
    Sebesta I; Krijt J; Fairbanks LD; Simmonds HA
    J Inherit Metab Dis; 1994; 17(1):133-4. PubMed ID: 8051924
    [No Abstract]   [Full Text] [Related]  

  • 9. The urinary excretion of orotic acid and orotidine, measured by an isotope dilution assay.
    Tax WJ; Veerkamp JH; Schretlen ED
    Clin Chim Acta; 1978 Dec; 90(3):217-23. PubMed ID: 365397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of allopurinol on purine- and pyrimidinesynthesis (author's transl)].
    Gröbner W; Zöllner N
    Klin Wochenschr; 1978 Mar; 53(16):255-60. PubMed ID: 682520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of allopurinol riboside.
    Shapiro TA; Were JB; Danso K; Nelson DJ; Desjardins RE; Pamplin CL
    Clin Pharmacol Ther; 1991 May; 49(5):506-14. PubMed ID: 2029827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.
    Hauser ER; Finkelstein JE; Valle D; Brusilow SW
    N Engl J Med; 1990 Jun; 322(23):1641-5. PubMed ID: 2342523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dose and age on the response of the allopurinol test for ornithine carbamoyltransferase deficiency in control infants.
    Riudor E; Arranz JA; Rodés M; Rubio V; Sentís M; Burlina AB
    J Inherit Metab Dis; 2000 Nov; 23(7):662-8. PubMed ID: 11117427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopurinol challenge test in children.
    Burlina AB; Ferrari V; Dionisi-Vici C; Bordugo A; Zacchello F; Tuchman M
    J Inherit Metab Dis; 1992; 15(5):707-12. PubMed ID: 1434508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxipurinol and allopurinol riboside on whewellite crystallization: in vitro and in vivo observations.
    Finlayson B; Burns J; Smith A; Du Bois L
    Invest Urol; 1979 Nov; 17(3):227-9. PubMed ID: 500322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orotidine accumulation in human erythrocytes during allopurinol therapy: association with high urinary oxypurinol-7-riboside concentrations in renal failure and in the Lesch-Nyhan syndrome.
    Simmonds HA; Reiter S; Davies PM; Cameron JS
    Clin Sci (Lond); 1991 Mar; 80(3):191-7. PubMed ID: 1850677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary purines, pyrimidines and nucleosides in uridine-treated orotic aciduria.
    Mill GC
    Clin Chim Acta; 1988 Jun; 174(3):337-43. PubMed ID: 3390959
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic studies of high doses of allopurinol in humans.
    Nelson DJ; Elion GB
    Adv Exp Med Biol; 1984; 165 Pt A():167-70. PubMed ID: 6720373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency.
    Arranz JA; Riudor E; Rodés M; Roig M; Climent C; Rubio V; Sentís M; Burlina A
    Clin Chem; 1999 Jul; 45(7):995-1001. PubMed ID: 10388475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quick cancer test developed.
    Lund AE
    J Am Dent Assoc; 1998 Aug; 129(8):1080, 1082. PubMed ID: 9715008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.